Familial HUS has been extensively considered in terms of alternative pathway activation, which might be increased due to factor H abnormalities or partial deficiency, which leads to hypocomplementemia (i.e., consumption of C3 and factor B) (96). The gene discussed is C3; the disease is hemolytic-uremic syndrome.